How Fred Hutch scientists tackle world’s top infectious killer, TB

But scientists are working toward better options. Shapiro was part of a committee that reviewed the evidence for a new TB tongue swab test, based on research from UW. Based on Shapiro and her colleagues’ recommendation, the WHO endorsed the approach earlier this month. The tongue swab test will help identify people with signs of … Read more

Niger reports over 17,000 tuberculosis cases in 2025-Xinhua

NIAMEY, March 24 (Xinhua) — Niger recorded 17,406 tuberculosis cases in 2025, including 13,607 new pulmonary ones, the most contagious form of the disease, Public Health Minister Colonel-Major Garba Hakimi has said. Speaking in a radio and television address Monday marking the World Tuberculosis Day on Tuesday, Hakimi cited a World Health Organization report that … Read more

Peng Liyuan calls for global action against TB

BEIJING – Peng Liyuan, wife of Chinese President Xi Jinping and also the World Health Organization (WHO) goodwill ambassador for tuberculosis (TB) and HIV/AIDS, on Wednesday called for international support and participation in global TB prevention and treatment. In a written statement to a virtual event commemorating the WHO World TB Day 2026, Peng said … Read more

Study uncovers how tuberculosis bacteria fuel themselves during infection

Researchers at The Hospital for Sick Children (SickKids) have uncovered how the bacteria that causes tuberculosis fuels itself during infection, providing new insights into one of the world’s deadliest infectious diseases.  The study, published in The EMBO Journal, provides the first detailed 3D structure of a protein called EtfD, which the bacterium Mycobacterium tuberculosis uses to extract energy from lipids (fats), along with the first laboratory … Read more

DNA origami vaccine platform shows promise against multiple infectious viruses

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID-19 in the first year alone. Their extraordinary effectiveness in having … Read more

New Antibiotics Show Promise in Disrupting Tuberculosis Bacteria

Archyde Tuberculosis (TB) remains one of the world’s most significant public health challenges, claiming an estimated 1.3 million lives in 2022 alone. The emergence of drug-resistant strains, particularly in regions like… You can read the full story here: New Antibiotics Show Promise in Disrupting Tuberculosis Bacteria. Source link

Experimental antibiotics disrupt bacterium that causes tuberculosis

Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments. Globally, TB remains a major health crisis, claiming around 1.2 million lives each year and ranking among the world’s deadliest infectious … Read more

Tuberculosis bacteria stiffen cell membranes to evade immune destruction

Scientists have uncovered an elegant biophysical trick that tuberculosis-causing bacteria use to survive inside human cells, a discovery that could lead to new strategies for fighting one of the world’s deadliest infectious diseases. Tuberculosis kills more than a million people each year and remains a major public health crisis, particularly in Asia, Africa and Latin … Read more

Modified peptides show promise against tuberculosis bacteria

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K. pneumoniae, Salmonella and Acinetobacter, according to a warning issued by the World Health Organization last October. For the microbe that gives rise to tuberculosis, a team of researchers from Penn State and The University of Minnesota Medical School found that a potential solution may be chemically … Read more

High adherence and safety found in short TB treatments

A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage of patients successfully completed both regimens and suffered few adverse side effects. A team led by Richard Chaisson, of the Johns Hopkins School of Medicine, U.S.A., reports these findings February 10th in the open access journal PLOS Medicine. … Read more